X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

Micromeritics Announces Instrument Grant to the Massachusetts Institute of Technology

Yuvraj_pawp by Yuvraj_pawp
31st March 2015
in Research & Development

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Micromeritics’ Instrument Grant Committee has recently selected its latest grant recipient.

A 3Flex Surface Characterisation Analyser was awarded to the Civil and Environmental Engineering Department of MIT.

MIT senior research scientist Dr Roland Pellenq said: “The department aims at determining the poro-mechanical and transport properties of the most important technological, economical and environmental materials in the world: cement and concrete, source rocks for oil and gas, oxide, glasses and clays for nuclear energy and nuclear waste storage.”

The company will use a ‘nanoscope’ method to scrutinise and manipulate materials in a broad range of magnifications.

Pore structure characterisation, including porosity assessment, pore size distribution, and specific surfaces are key factors in their approach and is the reason they applied for the Micromeritics gift award.

Dr Pellenq is one of the co-founders and lead scientist of the Concrete Sustainability Hub, CSH@MIT, an interdisciplinary research centre dedicated to the reduction of the environmental footprint of the cement and concrete industry.

The centre was opened in October 2009.

Dr Pellenq was hired as a MIT senior research scientist in November 2010 and is the director of the CNRS-MIT joint laboratory ‘Multiscale Material Science of Energy and Environment.’

Micromeritics president Preston Hendrix said: “This program is designed to promote and advance the acquisition and use of particle characterisation instrumentation in non-profit universities and institutions where other means of funding are not generally available.”

Mr Hendrix appointed a special Grant Selection Committee to ensure the success and effectiveness of the program.

Micromeritics’ Instrument Grant Program is intended to provide particle characterisation instruments to non-profit universities and research organisations to foster and support meritorious research projects.

A maximum of one instrument / integrated system will be awarded per calendar quarter.

Applications may be submitted anytime in accordance with the application instructions and will remain active for a period of one year from the date of submission.

Visit the Grant Program website for a detailed grant description, application requirements and application.

Previous Post

GSK to provide meningitis B vaccine in UK

Next Post

Novartis's Jadenu receives FDA approval to treat chronic iron overload

Related Posts

Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
wearable drug delivery devices
Insights

Wearable Drug Delivery Devices for On-Demand Care

27th September 2025
biologic drug formulation stability
Drug Development

Breakthroughs in Biologic Drug Formulation Stability

27th September 2025
high volume injectable formulations
Insights

Overcoming Challenges in High-Volume Injectable Formulations

27th September 2025
Insights

Green Chemistry in Sustainable API Manufacturing

26th September 2025
Next Post

Perrigo completes acquisition of OTC drugmaker Omega Pharma for $4.5bn

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In